Moberg Pharma announces launch in Japan and provides market update for Kerasal Nail and Emtrix
STOCKHOLM, June 28th, 2016. Moberg Pharma AB (OMX: MOB) today announced that its partner, Menarini Asia-Pacific, recently initiated the launch of Emtrix® in Japan and that the initial consumer response has been strong. In the U.S., Kerasal Nail® has further increased its market share following the recent repositioning of the brand.The roll-out of the global launch of Kerasal Nail/Emtrix is continuing. Recent highlights include: · The launch has been initiated in a part of Japan by Moberg Pharma’s partner Menarini Asia-Pacific. The initial consumer response has been strong with sales